Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis

BACKGROUND: Interferon-beta (IFNβ) is used to inhibit disease activity in multiple sclerosis (MS), but its mechanisms of action are incompletely understood, individual treatment response varies, and biological markers predicting response to treatment have yet to be identified. METHODS: The relations...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Rudick, Richard A., Rani, M. R. Sandhya, Xu, Yaomin, Lee, Jar-Chi, Na, Jie, Shrock, Jennifer, Josyula, Anupama, Fisher, Elizabeth, Ransohoff, Richard M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2011
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3094352/
https://ncbi.nlm.nih.gov/pubmed/21602934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0019262
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk